Skip to main content
. Author manuscript; available in PMC: 2024 Mar 25.
Published in final edited form as: Cancer Causes Control. 2023 Nov 27;35(4):661–669. doi: 10.1007/s10552-023-01822-8

Table 3.

HRs and 95% CI for immune cell proportions and liver cancer, in the Strong Heart Study

Immune cell subtype Model 1
Model 2
Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
CD8+ 1.44 (0.99, 2.10) 0.06 1.46 (1.02, 2.10) 0.04 1.14 (0.70, 1.85) 0.61
CD4+ 0.92 (0.59, 1.44) 0.72 0.96 (0.62, 1.51) 0.87 0.82 (0.50, 1.36) 0.45
Natural killer 1.55 (1.07, 2.26) 0.02 1.54 (1.05, 2.26) 0.03 1.41 (0.85, 2.33) 0.18
B-lymphocytes 1.36 (0.93, 2.00) 0.12 1.35 (0.93, 1.96) 0.12 1.37 (0.89, 2.12) 0.16
Monocytes 1.09 (0.71, 1.65) 0.7 1.03 (0.69, 1.56) 0.87 0.88 (0.55, 1.42) 0.61
Granulocytes 0.69 (0.44, 1.07) 0.09 0.67 (0.43, 1.04) 0.08 0.69 (0.41, 1.01) 0.1

The HR is reported per SD of proportion for each cell counts

Model 1: age, sex and center

Model 2: model 1 + alcohol (ever/current vs never), smoking (ever/current vs never), BMI and LDL